USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Medtentia International Ltd Oy

USPTO PatentsView assignee record - 38 granted patents across 4 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Medtentia ranks #8,435 of 49,997 tracked US assignees by granted-patent volume, with 38 patents across 4 technology areas.

#8,435
of 49,997 US assignees by volume
39th percentile
by Innovation Score (31.8/100)
14.0
avg claims per patent
+24%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8435 · Foreign Corporation #8,435 · 38 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 38 grants
  • UPPER-Q #8,435/49,997
  • PHOTO-FINISH Malwarebytes
  • CPC-NARROW A61F · 4 areas
  • INNOV-THIN 31.8/100
  • CLAIMS-RICH 14.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-UP +24% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Malwarebytes Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Medtentia’s 31.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Medtentia

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Medtentia's Innovation Score is 31.8/100 (39th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Medtentia?

Each dot is one of Medtentia’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Medtentia’s own 14.0 claims/patent is at or below the 16.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Medtentia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 37.938.038.03838.038.038.1 0510152025 Granted patents (volume) Avg claims / patent Malwarebytes Inc. - 38, 18.34MalwarebytesMarvin Lumber and Cedar Company, LLC - 38, 21.87Marvin Lumber and…McCain Foods Limited - 38, 4.39Mccain FoodsMcKesson Financial Holdings Unlimited Company - 38, 18.08Mckesson Financia…Merative US L.P. - 38, 18.08Merative USMicronas GmbH - 38, 14.03MicronasMikron Industries, Inc. - 38, 1.45Mikron IndustriesMinimax GmbH & Co KG - 38, 16.21Minimax & KGMedtentia International Ltd Oy - 38, 14.03Medtentia Interna…
Medtentia vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Medtentia's grants concentrate

Medtentia International Ltd Oy is a focused PatentsView assignee: 4 CPC subclasses with 97.4% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2019 (10 grants) versus a trough of 2 in 2015. By volume, Medtentia sits between Malwarebytes Inc. and Minimax GmbH & Co KG.

Medtentia's three-year grant acceleration

From 2019–2021 to 2022–2024, Medtentia International Ltd Oy moved from 20 to 11 grants (0.55x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Medtentia's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Medtentia holds 38 patents at rank #8,440, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Medtentia

By rank, the assignees closest to #8,440 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Medtentia's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Medtentia, neither rank-band nor same-CPC leaders (those blocks stay above). In A61F (Filters Implantable Into Blood Vessels), Medtentia ranks #174 of 3,082 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (32 here).

Medtentia's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 39th percentile higher than 39% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

024681012 20152016201820192020202120222023 4
USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Medtentia International Ltd Oy patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 5.3%
2016 2 5.3%
2018 3 7.9%
2019 10 26.3%
2020 5 13.2%
2021 5 13.2%
2022 7 18.4%
2023 4 10.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Medtentia International Ltd Oy's patent record in context - here's where to go next.

  • Medtentia International Ltd Oy's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 97.4% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #8,435 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Medtentia International Ltd Oy against Malwarebytes Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 31.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.